Article - 28 August 2024 “It was pretty much hell for a year”: A Labcorp employee’s journey with dermatomyositis
Poster - 21 February 2024 Novel Diagnostic Markers for Rheumatoid Arthritis Including Anti-CarP (Carbamylated Protein), Anti-Sa (Citrullinated Vimentin) and Anti-CEP1 (Citrullinated Enolase Peptide1) Are Frequently Positive in Diagnostic Profiles
Poster - 21 February 2024 Therapeutic Drug Monitoring (TDM) of Hydroxychloroquine in Whole Blood: Analysis of Over 10,000 Patient Results Using Lab Developed Liquid Chromatography Tandem Mass Spectrometry
Poster - 21 February 2024 Novel Diagnostic Markers for Rheumatoid Arthritis Including Anti-CarP (Carbamylated Protein), Anti-Sa (Citrullinated Vimentin) and Anti-CEP1 (Citrullinated Enolase Peptide1) Are Frequently Positive in Diagnostic Profiles Read Moreabout Novel Diagnostic Markers for Rheumatoid Arthritis Including Anti-CarP (Carbamylated Protein), Anti-Sa (Citrullinated Vimentin) and Anti-CEP1 (Citrullinated Enolase Peptide1) Are Frequently Positive in Diagnostic Profiles
Poster - 21 February 2024 Therapeutic Drug Monitoring (TDM) of Hydroxychloroquine in Whole Blood: Analysis of Over 10,000 Patient Results Using Lab Developed Liquid Chromatography Tandem Mass Spectrometry Read Moreabout Therapeutic Drug Monitoring (TDM) of Hydroxychloroquine in Whole Blood: Analysis of Over 10,000 Patient Results Using Lab Developed Liquid Chromatography Tandem Mass Spectrometry
Poster - 21 February 2024 Correlation of Anti-DFS70 Autoantibodies by ELISA with HEp-2 Cells DFS Pattern by IFA Read Moreabout Correlation of Anti-DFS70 Autoantibodies by ELISA with HEp-2 Cells DFS Pattern by IFA
Poster - 21 February 2024 Rheumatologic Disorder Diagnostic Testing Patterns: Real World Evidence from a National Laboratory Database Read Moreabout Rheumatologic Disorder Diagnostic Testing Patterns: Real World Evidence from a National Laboratory Database
Poster - 21 February 2024 Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples Read Moreabout Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples
Poster - 21 February 2024 Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores Read Moreabout Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores
Poster - 20 February 2024 Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens Read Moreabout Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens
Poster - 16 November 2019 Pro-inflammatory small LDL-like particles in patients with severe liver disease Read Moreabout Pro-inflammatory small LDL-like particles in patients with severe liver disease
Poster - 19 October 2019 Measurement of inflammatory cytokines and neurodegenerative/injury biomarkers in acute concussion/mild traumatic brain injury (c/mTBI) serum and saliva samples Read Moreabout Measurement of inflammatory cytokines and neurodegenerative/injury biomarkers in acute concussion/mild traumatic brain injury (c/mTBI) serum and saliva samples
Poster - 1 May 2019 Spinal muscular atrophy: Ordering trends pre- and post-ACOG Committee Opinion 691 Read Moreabout Spinal muscular atrophy: Ordering trends pre- and post-ACOG Committee Opinion 691
Poster - 10 November 2018 The novel inflammatory marker GlycA and the prevalence and progressions of valvular and thoracic aortic calcification: The multi-ethnic study of atherosclerosis Read Moreabout The novel inflammatory marker GlycA and the prevalence and progressions of valvular and thoracic aortic calcification: The multi-ethnic study of atherosclerosis
Poster - 1 November 2018 GlycA, a novel inflammatory marker, and its association with peripheral arterial disease and carotid plaque: The multi-ethnic study of atherosclerosis Read Moreabout GlycA, a novel inflammatory marker, and its association with peripheral arterial disease and carotid plaque: The multi-ethnic study of atherosclerosis
Poster - 10 June 2018 Impact of microRNA-33a/b antagonism on atherosclerosis regression and stabilization in a nonhuman primate model Read Moreabout Impact of microRNA-33a/b antagonism on atherosclerosis regression and stabilization in a nonhuman primate model
Article - 28 August 2024 How a patient with dermatomyositis adjusted to a life without the sun Read Moreabout How a patient with dermatomyositis adjusted to a life without the sun
Article - 28 August 2024 “It was pretty much hell for a year”: A Labcorp employee’s journey with dermatomyositis Read Moreabout “It was pretty much hell for a year”: A Labcorp employee’s journey with dermatomyositis
Article - 7 June 2023 Celebrating three years of building on RDL’s legacy Read Moreabout Celebrating three years of building on RDL’s legacy